The Pulmonary Fibrosis Foundation (PFF) Summit 2019 is being held 7 – 9 November in San Antonio, Texas.
RepeatDx is pleased to announce that they will be exhibiting at the PFF Summit 2019. The Summit is the PFF’s fifth biennial international health care conference on pulmonary fibrosis (PF). The goal of the Summit is to foster a collaborative environment to improve education and awareness of PF and to identify new approaches to treat, and ultimately cure, this disease.
PF is a growing area of focus for RepeatDx, the leading clinical diagnostic laboratory specializing in telomere length testing.
Studies have shown that leukocyte telomere length is independently associated with survival outcomes for PF patients. There are very real benefits to measuring the telomere length of patients with PF, including improving disease course prediction. In addition, telomere length can guide treatment choices, including lung transplantation timing and post-transplant care, both of which are active areas of clinical research.
Ultimately, providing vital information on telomere measurements to doctors and individuals with PF can help them to make better-informed choices about treatments.
RepeatDx is proud to support the important work of the PFF and will have an exhibit table in the Exhibition Hall for the duration of the Summit. The team is looking forward to talking to patients, clinicians and researchers about the role that telomere length analysis can play in the diagnosis and treatment of PF.
Find out more and register to attend the PFF Summit 2019 here.
You can find out more about telomere testing and PF on our website.